The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: Evidence from a multicentre study in Spain

Human Reproduction

Volumn 16, Issue 12, 2001, Pages 2525-2532

  Burgues S ^a   Balasch, J ^b   Fabregues F ^b   Barri, P ^c   Tur, R ^c   Caballero, P ^d   Heredia, J R ^d   Calaf, J ^e   Espinos J ^e   Cano, I ^f   Perez De La Blanca E ^f   De Castro Pita, F J ^g   Duque, J A ^h   Garcia S ^h   Herruzo, A ⁱ   Martinez L ⁱ   Lopez E ^j   Ordas J ^k   Cuadrado, C ^k   Pellicer, A ^l   Requena, A ^l   Rodriguez Escudero F J ^m   Neyro, J L ^m   Romeu, A ⁿ   Quintero, L A ⁿ   Ruiz Balda, J A ^o   Alonso, J ^o   more..

^a Laboratorios Serono Madrid   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c INSTITUT UNIVERSITARI DEXEUS   (Spain)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

^e HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^f HOSPITAL MATERNO INFANTIL   (Spain)

^g HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^h HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^m HOSPITAL DE CRUCES   (Spain)

ⁿ HOSPITAL UNIVERSITARIO LA FE   (Spain)

^o HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

more..

Author keywords

Hypogonadotrophic anovulation; Ovulation induction; rFSH; rLH; WHO group I anovulation

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE;

ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; FEMALE; FEMALE INFERTILITY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MULTICENTER STUDY; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; SPAIN; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

FALLOPIA;

EID: 0035657663     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.12.2525     Document Type: Article

References (31)

1. Pregnancy after treatment with three recombinant gonadotrophins
2. Induction of ovarian follicle development and ovulation with exogenous gonadotrophins
3. The role of luteinizing hormone in human follicle development and oocyte fertility: Evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone
4. Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization
5. Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process
6. Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotrophin deficiency
7. Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction
8. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: A meta-analysis
9. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: Prognostic factors and clinical results in 600 cycles
10. Ovarian response to purified FSH in infertile women with long-standing hypogonadotropic hypogonadism
11. Controlled ovarian hyperstimulation using highly purified FSH results in a lower serum ooestradiol profile in the follicular phase as compared with HMG
12. Ovarian hyperstimulation syndrome: An update review
13. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis
14. Recombinant human luteinizing hormone: An effective new gonadotropin preparation
15. Ovulation induction in the nonestrogenized patient
16. Gonadotropin therapy: New trends and insights
17. Successful induction of ovulation and completed pregnancy using recombinant luteinizing hormone and follicle stimulating hormone in a woman with Kallman's syndrome
18. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome
19. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH
20. Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone
21. Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay
22. Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization
23. Hypogonadotropic disorders in men and women: Diagnosis and therapy with pulsatile gonadotropin releasing hormone
24. Human recombinant follicle stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency
25. Recombinant human follicle-stimulating hormone and ovarian response in gonadotropic-deficient women
26. Results of ovulation induction using human menopausal gonadotropin or purified follicle stimulating-hormone in hypogonadotropic hypogonadism patients
27. Anovulatory infertility
28. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: A dose-finding study
29. Agents stimulating gonadal function in the human